BROOKE DEES: Open Payments
NPI 1912469156 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 31 payments from 12 companies in 2025. Trend: 2023 $751 · 2024 $677 · 2025 $823
Food & beverage: $823
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $219 |
| E.R. Squibb & Sons, L.L.C. | 9 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| Baxter Healthcare | 2 | $81 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $58 |
| ABIOMED | 1 | $41 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: PASCAL, CAMZYOS, LEQVIO, Hillrom - Carnation Ambulatory Monitor, LifeVest, VYNDAQEL, REPATHA, JARDIANCE.
Industry payments across MS — which companies pay providers there.
